{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:06:23Z","timestamp":1746097583936},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open access funding provided by Universit\u00e0 degli Studi di Torino within the CRUI-CARE Agreement."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To verify the correct decision-making procedure on performing an intravitreal injection by investigating the in vivo wound morphology and evolution of 22-gauge wounds after dexamethasone oblique injection with anterior segment optical coherence tomography (OCT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design<\/jats:title>\n                <jats:p>Prospective, observational consecutive case series.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Subjects underwent a dexamethasone injection at University Eye Clinic of Turin. All the injections have been performed in an oblique (aka beveled or angled) fashion. Patients were divided according to the number of injections already performed with dexamethasone. Group 1 consisted of patients at the first injection, group 2 of patients at a second or more injection always in the same quadrant, and group 3 of patients at the second or more injection in a different quadrant. The incisions were imaged with the Heidelberg SPECTRALIS OCT device on postoperative days 1, 8, and 15. The main outcome measure was wound structure\/characteristics (e.g., presence of gaping) as evaluated with OCT. Surgical and ocular parameters were also recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-three consecutive patients were investigated. OCT demonstrated closed wounds in all eyes on postoperative days 1, 8, and 15. In all patients, the external (entry) side of the incision was seen as a gape; however, the rest of the wound was closed. No complications were recorded in the different patients during the follow-up. In patients of group 1, we identified the scleral pathway in 10 eyes at day 1. At 8\u00a0days in 9 of 10 eyes, the sclera had returned to its <jats:italic>restitutio ad integrum<\/jats:italic>. In patients of group 2, the scleral pathway was recognizable on the first day of control; in 7 patients, this was accompanied by the presence of intrascleral edema with peri-wound fluid. At the 8-day checkup, 3 eyes still showed signs attributable to the intrascleral pathway accompanied by peri-wound edema. In group 3, it was possible to identify the intrascleral pathway in 8 patients. There were no signs of intrascleral peri-wound edema or other anatomical changes in 9 patients as early as the first day. In the 8-day follow-up, the signs of scleral edema were absent in the single patient who presented them. At 15\u00a0days, there were no signs of scleral pathway in all eyes analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Speaking of intravitreal injections of slow-release dexamethasone, the technique that involves moving the conjunctiva and a beveled or angled sclerotomy after a careful choice of the injection site, paying attention to vary the quadrant involved with each puncture, reduces the number of days of closure of the sclera via and the scleral damage, thus protecting the patient from complications. For the future, it is hoped that the operating microscope and intraoperative OCT will be used on every occasion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-022-05650-5","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T06:02:53Z","timestamp":1650952973000},"page":"2819-2828","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intravitreal dexamethasone: variation of surgical technique and prevention of ocular complications with ASOCT follow-up"],"prefix":"10.1007","volume":"260","author":[{"given":"Raffaele","family":"Nuzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"issue":"3","key":"5650_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000343643","volume":"3","author":"F Matonti","year":"2012","unstructured":"Matonti F, Hoffart L, Baeteman C, Denis D (2012) Repeated treatment for macular edema in vein occlusion by intravitreal implant of dexamethasone Case Rep. Ophthalmol 3(3):339\u2013342. https:\/\/doi.org\/10.1159\/000343643","journal-title":"Ophthalmol"},{"key":"5650_CR2","doi-asserted-by":"publisher","unstructured":"Haller JA, Bandello F (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117 (6). https:\/\/doi.org\/10.1016\/J.OPHTHA.2010.03.032","DOI":"10.1016\/J.OPHTHA.2010.03.032"},{"issue":"12","key":"5650_CR3","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/J.OPHTHA.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller JA, Julia A, Bandello F, Belfort R et al (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118(12):2453\u20132460. https:\/\/doi.org\/10.1016\/J.OPHTHA.2011.05.014","journal-title":"Ophthalmology"},{"issue":"1","key":"5650_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/OPTH.S15783","volume":"5","author":"R Herrero-Vanrell","year":"2011","unstructured":"Herrero-Vanrell R, Cardillo JA, Kuppermann BD (2011) Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 5(1):139\u2013146. https:\/\/doi.org\/10.2147\/OPTH.S15783","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"5650_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/IAE.0B013E318206D18C","volume":"31","author":"DS Boyer","year":"2011","unstructured":"Boyer DS, Faber D, Gupta S et al (2011) Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 31(5):915\u2013923. https:\/\/doi.org\/10.1097\/IAE.0B013E318206D18C","journal-title":"Retina"},{"issue":"2","key":"5650_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000336225","volume":"228","author":"I Zucchiatti","year":"2012","unstructured":"Zucchiatti I, Lattanzio R, Querques G et al (2012) Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 228(2):117\u2013122. https:\/\/doi.org\/10.1159\/000336225","journal-title":"Ophthalmologica"},{"key":"5650_CR7","doi-asserted-by":"publisher","unstructured":"Meyer LM, Sch\u00f6nfeld CL (2012) Cystoid macular edema after complicated cataract surgery resolved by an intravitreal dexamethasone 0.7-mg implant Case Rep. Ophthalmol., vol. 2, no. 3, pp. 319\u2013322, doi: https:\/\/doi.org\/10.1159\/000332424.","DOI":"10.1159\/000332424"},{"issue":"1","key":"5650_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000337481","volume":"3","author":"S Mart\u00ednez-Castillo","year":"2012","unstructured":"Mart\u00ednez-Castillo S, Gallego-Pinazo R, Dolz-Marco R et al (2012) Adult coats\u2019 disease successfully managed with the dexamethasone intravitreal implant (ozurdex\u00ae) combined with retinal photocoagulation Case Rep. Ophthalmol 3(1):123\u2013127. https:\/\/doi.org\/10.1159\/000337481","journal-title":"Ophthalmol"},{"issue":"1","key":"5650_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000337144","volume":"3","author":"A Russo","year":"2012","unstructured":"Russo A, Avitabile T, Uva M et al (2012) Radiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0 7-mg implant. Case Rep Ophthalmol 3(1):71\u201376. https:\/\/doi.org\/10.1159\/000337144","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"5650_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000479785","volume":"8","author":"R Nuzzi","year":"2017","unstructured":"Nuzzi R, Monteu F (2017) Use of intravitreal dexamethasone in a case of anterior ischemic optic neuropathy. Case Rep Ophthalmol 8(2):452\u2013458. https:\/\/doi.org\/10.1159\/000479785","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"5650_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/08820538.2013.835833","volume":"30","author":"R Nuzzi","year":"2015","unstructured":"Nuzzi R, Tridico F (2015) Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study. Semin Ophthalmol 30(2):129\u2013135. https:\/\/doi.org\/10.3109\/08820538.2013.835833","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"5650_CR12","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.3928\/23258160-20190129-14","volume":"50","author":"CJ Krambeer","year":"2019","unstructured":"Krambeer CJ, Wannamaker KW (2019) A new suggested strategy for safe injection of ozurdex. Ophthalmic Surg Lasers Imaging Retina 50(2):E23\u2013E25. https:\/\/doi.org\/10.3928\/23258160-20190129-14","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"5650_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.AJO.2008.07.046","volume":"147","author":"M Taban","year":"2009","unstructured":"Taban M, Sharma S, Ventura AACM, Kaiser P (2009) Evaluation of wound closure in oblique 23-gauge sutureless sclerotomies with visante optical coherence tomography. Am J Ophthalmol 147(1):101-107.e1. https:\/\/doi.org\/10.1016\/J.AJO.2008.07.046","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"5650_CR14","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/J.OPHTHA.2015.07.005","volume":"122","author":"BL VanderBeek","year":"2015","unstructured":"VanderBeek BL, Bonaffini SG, Ma L (2015) The association between intravitreal steroids and post-injection endophthalmitis rates. Ophthalmology 122(11):2311-2315.e1. https:\/\/doi.org\/10.1016\/J.OPHTHA.2015.07.005","journal-title":"Ophthalmology"},{"key":"5650_CR15","unstructured":"Department Of Health And Human Services (2014) Approval for Ozurdex, dexamethasone intravitreal implant https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/022315Orig1s009.pdf. Accessed 28 Jun 2014"},{"issue":"12","key":"5650_CR16","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/J.OPHTHA.2007.08.009","volume":"114","author":"DY Kunimoto","year":"2007","unstructured":"Kunimoto DY, Kaiser RS (2007) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 114(12):2133\u20132137. https:\/\/doi.org\/10.1016\/J.OPHTHA.2007.08.009","journal-title":"Ophthalmology"},{"issue":"1","key":"5650_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/IAE.0b013e31815e9313","volume":"28","author":"IU Scott","year":"2008","unstructured":"Scott IU, Flynn HW Jr, Dev S, Shaikh S, Mittra RA, Arevalo JF, Kychenthal A, Acar N (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 28(1):138\u2013142. https:\/\/doi.org\/10.1097\/IAE.0b013e31815e9313","journal-title":"Retina"},{"issue":"10","key":"5650_CR18","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/s0161-6420(02)01119-3","volume":"109","author":"GY Fujii","year":"2002","unstructured":"Fujii GY, De Juan Jr E, Humayun MS, Chang TS, Pieramici DJ, Barnes A, Kent D (2002) Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 109(10):1814\u20131820. https:\/\/doi.org\/10.1016\/s0161-6420(02)01119-3","journal-title":"Ophthalmology"},{"issue":"4","key":"5650_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/IAE.0b013e318162b008","volume":"28","author":"N Acar","year":"2008","unstructured":"Acar N, Kapran Z, Unver YB, Altan T, Ozdogan S (2008) Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. Retina 28(4):545\u2013552. https:\/\/doi.org\/10.1097\/IAE.0b013e318162b008","journal-title":"Retina"},{"issue":"5","key":"5650_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ajo.2006.05.057","volume":"142","author":"H Shimada","year":"2006","unstructured":"Shimada H, Nakashizuka H, Mori R, Mizutani Y, Hattori T (2006) 25-gauge scleral tunnel transconjunctival vitrectomy. Am J Ophthalmol 142(5):871\u2013873. https:\/\/doi.org\/10.1016\/j.ajo.2006.05.057","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"5650_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ajo.2006.01.037","volume":"141","author":"L L\u00f3pez-Guajardo","year":"2006","unstructured":"L\u00f3pez-Guajardo L, Pareja-Esteban J, Teus-Guezala MA (2006) Oblique sclerotomy technique for prevention of incompetent wound closure in transconjunctival 25-gauge vitrectomy. Am J Ophthalmol 141(6):1154\u20131156. https:\/\/doi.org\/10.1016\/j.ajo.2006.01.037","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"5650_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1442-9071.2007.01580.x","volume":"35","author":"M Inoue","year":"2007","unstructured":"Inoue M, Shinoda K, Shinoda H, Kawamura R, Suzuki K, Ishida S (2007) Two-step oblique incision during 25-gauge vitrectomy reduces incidence of postoperative hypotony. Clin Exp Ophthalmol 35(8):693\u2013696. https:\/\/doi.org\/10.1111\/j.1442-9071.2007.01580.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5650_CR23","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2147\/OPTH.S263474","volume":"14","author":"R Nuzzi","year":"2020","unstructured":"Nuzzi R, Scalabrin S, Becco A (2020) Reduction of intraocular pressure spikes due to intravitreal bevacizumab injections by scleral indentation with cotton swab or digital ocular massage: innovative techniques compared. Clin Ophthalmol 14:2533\u20132541. https:\/\/doi.org\/10.2147\/OPTH.S263474","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"5650_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/IAE.0b013e31816690d4","volume":"28","author":"A Singh","year":"2008","unstructured":"Singh A, Chen JA, Stewart JM (2008) Ocular surface fluid contamination of sutureless 25-gauge vitrectomy incisions. Retina 28(4):553\u2013557. https:\/\/doi.org\/10.1097\/IAE.0b013e31816690d4","journal-title":"Retina"},{"issue":"12","key":"5650_CR25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.ophtha.2008.08.027","volume":"115","author":"M Taban","year":"2008","unstructured":"Taban M, Ventura AA, Sharma S, Kaiser PK (2008) Dynamic evaluation of sutureless vitrectomy wounds: an optical coherence tomography and histopathology study. Ophthalmology 115(12):2221\u20132228. https:\/\/doi.org\/10.1016\/j.ophtha.2008.08.027","journal-title":"Ophthalmology"},{"issue":"12","key":"5650_CR26","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/J.OPHTHA.2012.08.033","volume":"119","author":"G Garay-Aramburu","year":"2012","unstructured":"Garay-Aramburu G, Cabrerizo J (2012) Intravitreal injection technique. Ophthalmology 119(12):2654-2655.e1. https:\/\/doi.org\/10.1016\/J.OPHTHA.2012.08.033","journal-title":"Ophthalmology"},{"key":"5650_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/S00417-021-05087-2","author":"R Nuzzi","year":"2021","unstructured":"Nuzzi R, Rossi A (2021) Diagnostic imaging versus surgical procedure: intra- and postoperative OCT evaluation of sutureless scleral-fixated intraocular lens implantation and possible related complications. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/S00417-021-05087-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05650-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:08:14Z","timestamp":1661508494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5650"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05650-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for the figures and the data elaborated in the present manuscript has been obtained from the subject of this study, in written form. Our institution stated that no formal ethical approval was needed for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}